Due to regulatory restrictions regarding the distribution of financial research, this report is restricted to a specific region or investor type. Get access to exclusive reports by answering the questions below.
This combination of email and password didn't match our records. Your account might not be activated. If so, please click on the link we sent you via email. You can also request a password reset or a new activation email using the links below.
MORE FILTERS
We have evaluated Similarweb data for April. Aggregated traffic to e-com sites up 4% y-o-y. Rugvista traffic growth continues, don't fear RVRC's -19% y-o-y.
Continued market softness, Q1 org. growth -14% y-o-y. Significant 260bp EBITA margin improvement y-o-y. We reiterate BUY, covenant relief until '26 gives leverage headroom.
Things will get worse before they get better Minor estimate changes on limited incremental info Trading at 10x-6x ‘23e-‘24e EV/EBITA, BUY, TP 20
Trading update 11/10 means much was pre-reported Key takeaways: soft margin a result of a variety of factors We see no reason for a share reaction
Q3 figures pre-reported as of 11 Oct Q3 sales were SEK 3,107m, adj. EBITA SEK 48m Confirms soft view, cash flow worse than feared
Q2 EBITA was 18% above expectations Working capital a core focus forward Estimates up 1-3%, TP unchanged at SEK 80
Sales 10% vs ABGSC, 9% vs cons Adj. EBIT 17% vs ABGSC, 18% vs cons Cons likely up low-to-mid single digits
Q2 report due on 20 July Q2e sales & adj. EBIT of SEK 3,547m & SEK 139m Ests. down 24-7% ‘22e-‘24e – TP of SEK 80 (110)
Exploring conditions to issue shares worth SEK 1bn Would de-leverage balance sheet by ~1x Positive for the long-term story
Q1 report was 7% above expectations ‘22e-‘24e EBITA up 4-2% We raise our TP to SEK 110 (105): BUY
Sales +2% vs. ABG -1% vs. cons. Adj. EBIT +15% vs. ABG +7% vs. cons We expect cons. estimates +0-2%
Q1 report due on 27 April Inflation hits consumer demand We lower our ’22e-’24e EBITA by 19-7%
Q4 was strong, beating cons. by 17% We raise our EBIT adj. estimates by 7% TP up to SEK 125 (115), keep BUY
Sales 12% vs. ABGSCe, 13% vs. cons. Adj. EBIT 16% vs. ABGSCe, 17% vs. cons. Cons. likely up 5-10%, share likely +10%
Initiating rated coverage of BHG Group Derating offers attractive entry point BUY; TP SEK 115 per share
ABGSC ceases coverage of BHG Group Coverage will be transferred to institutional research Last published estimates are shown in this report
3.1pp margin drop and soft cash flows We fear that org. growth rates could come down in Q4 Adj. EBIT estimates trimmed by 5% and 4% (’22-’23e)
Save your current filters as a new Interest
Would you like to receive real-time email alerts when a new report is published under this interest?
These search results will show up under 'Saved searches' in the left panel
Would you like to receive real-time email when a new report matches this search?
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.